The 16th Annual Drug Discovery Innovation Forum #DDIF
10th & 11th September 2025
The Hyatt Regency Barcelona Tower, Spain
Co-located
16th Annual Drug Discovery Innovation Forum 2025
10th & 11th September 2025
Co-located with The 8th Annual Cell & Gene Therapy Innovation Forum #CGTI
16th Annual Drug Discovery Innovation Forum 2025
Chief System Scientist Exscientia
Richard Bickerton
Chief Science & Technology Officer
Merck
Laura Matz
Chris Gibson
CEO
Recursion
Chief Operating Officer
Evotec
Craig Johnstone
CEO
Iambic Therapeutics
Fred Manby
Ashwini Ghogare
Head of AI and Automation for Drug Discovery
Merck
PAST SPEAKERS
Laura Matz
Chief Scientific and Technology Officer
Merck
Richard Bickerton
Chief System Scientist
Exscientia
Chris Gibson
CEO
Recursion
Fred Manby
CEO
Iambic Therapeutics
Craig Johnstone
Chief Operating Officer
Evotec
Ashwini Ghogare
Head of AI and Automation for Drug Discovery
Merck
Leaders shaping the future of drug discovery and beyond
KEYNOTES & ADVISORY
“Our very survival depends on our ability to stay awake, to adjust to new ideas, to remain vigilant and to face the challenge of change.” – Martin Luther King
DDIF was formed 16 years ago and our mission remains the same - to push boundaries to affect change, for patients.
The 16th Annual Drug Discovery and Development forum brings together c-suite, executives, pioneering thinkers and leading academics who are committed to breaking free from traditional silos to evolve and make an impact. Our curated programme is for leaders interested in strategy and innovation by embracing next-generation technology such as ML, AR, Generative AI, LLM and so forth. To truly reduce drug discovery time and accelerate clinical trial development, we must advance towards digital transformation. There is no avoiding it.
Werngard Czechtizky
Executive Director Head Medicinal Chemistry, Respiratory and Immunology at AstraZeneca